Rockefeller Capital Management L.P. Purchases New Shares in Grail, Inc. (NASDAQ:GRAL)

Rockefeller Capital Management L.P. purchased a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 139,489 shares of the company's stock, valued at approximately $2,490,000. Rockefeller Capital Management L.P. owned 0.42% of Grail as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in GRAL. FNY Investment Advisers LLC acquired a new stake in shares of Grail during the fourth quarter worth about $26,000. Lindbrook Capital LLC bought a new stake in Grail during the 4th quarter worth approximately $28,000. Sterling Capital Management LLC acquired a new stake in Grail during the 4th quarter worth approximately $29,000. Wellington Shields Capital Management LLC bought a new position in Grail in the fourth quarter valued at approximately $33,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Grail in the fourth quarter valued at approximately $59,000.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on GRAL shares. Morgan Stanley boosted their price objective on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group started coverage on Grail in a research report on Monday. They issued a "buy" rating and a $32.00 target price on the stock.

Grail Price Performance

Shares of NASDAQ:GRAL traded down $0.35 during midday trading on Friday, reaching $37.34. The company had a trading volume of 378,314 shares, compared to its average volume of 1,220,651. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99. The business's 50 day moving average price is $31.34 and its 200 day moving average price is $24.09.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. As a group, sell-side analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Transactions at Grail

In other Grail news, President Joshua J. Ofman sold 2,109 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now owns 559,673 shares in the company, valued at $17,461,797.60. This represents a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now owns 335,170 shares of the company's stock, valued at $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,550 shares of company stock worth $360,436 in the last ninety days.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.